Medicines for rare and paediatric diseases have been successfully enabled through the EU’s incentives...
OPINION
Experts Point of View
The past two years could be called the years of messenger RNA (mRNA) technology, with two major biotech...
The COVID-19 pandemic has demonstrated how vulnerable human beings and societies are to a new infectious...
New entrants and variants will be main drivers of the COVID-19 vaccine market as supply gradually begins
to...
The Commission study on Novel Genomic Techniques (NGTs) underlines that plants resulting from NGTs have the...
IP U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents:
President Joe Biden...
Share
